Neuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc. (NEUP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NEUP · as of Jun 9, 2026
Key Statistics
Explore Neuphoria Therapeutics Inc. Data
neup stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
The NEUP analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $7.00, representing +49.89% upside from the current price of $4.67.
Competitors & Peers
neup competitorsNEUP
ALZN
APRE
BCDA
BMRA
CHEKStock Performance
Full HistoryAbout Neuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc. Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the in…
what is neuphoria therapeutics inc. · neup stock overview · neuphoria therapeutics inc. company profile · who is neuphoria therapeutics inc. ceo · neup NASDAQ · neuphoria therapeutics inc. headquarters · neuphoria therapeutics inc. business segments
About Stock Overview & Key Data
Neuphoria Therapeutics Inc. (NEUP) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on NASDAQ since Dec 16, 2021. As of the latest trading session, NEUP stock price is $4.67, with a market capitalization of $25.2M. The stock has returned -31.52% over the past 12 months and +20.36% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Neuphoria Therapeutics Inc. stock is Buy, with an average 12-month price target of $7.00. In fiscal year 2025, Neuphoria Therapeutics Inc. reported revenue of $15.6M and net income of -$369632.00. For detailed data — including Neuphoria Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Neuphoria Therapeutics Inc. (NEUP) stock price is $4.67. The stock is traded on NASDAQ under the ticker symbol NEUP. The 52-week range is $3.65 – $21.40.